Glaxosmithkline | GSK - Market Capitalization

Stock Price
54.68
Daily Change
-4.44 -7.51%
Monthly
-7.73%
Yearly
40.31%
Q2 Forecast
53.52

Glaxosmithkline reported GBP112.78B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Aurora Cannabis CAD 327.21M 142.93M Dec/2025
Bausch Health Companies USD 2.58B 194.9M Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Drreddys Laboratories INR 11.69B 50M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
J&J USD 561.65B 17.5B Apr/2026
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.97B 105M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 101.43B 1.16B Apr/2026
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025